← Back to Discover
DIADEMA PARTNERS LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $791,347,834
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- VIKING THERAPEUTICS INC · COM · 92686J106 · shares · CALL: $47,623,408
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares · CALL: $46,534,392
- BRISTOL-MYERS SQUIBB CO · COM · 110122108 · shares · CALL: $34,572,000
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares · PUT: $33,634,824
- UNITED THERAPEUTICS CORP DEL · COM · 91307C102 · shares: $28,711,030
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $26,072,747
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $21,598,038
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $19,104,797
- BRISTOL-MYERS SQUIBB CO · COM · 110122108 · shares · PUT: $19,049,172
- BRIDGEBIO PHARMA INC · NOTE 1.750% 3/0 · 10806XAJ1 · principal: $18,620,000
Reported holdings
149 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| VIKING THERAPEUTICS INC | COM | 92686J106 | CALL | 1,220,800 shares | $47,623,408 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | CALL | 349,200 shares | $46,534,392 |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | CALL | 600,000 shares | $34,572,000 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | PUT | 252,400 shares | $33,634,824 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 52,989 shares | $28,711,030 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 139,218 shares | $26,072,747 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 163,644 shares | $21,598,038 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 493,664 shares | $19,104,797 |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | PUT | 330,600 shares | $19,049,172 |
| BRIDGEBIO PHARMA INC | NOTE 1.750% 3/0 | 10806XAJ1 | — | 250,000 principal | $18,620,000 |
| CORCEPT THERAPEUTICS INC | COM | 218352102 | CALL | 206,300 shares | $17,937,785 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 312,846 shares | $17,901,048 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | — | 441,808 shares | $17,234,930 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | CALL | 149,700 shares | $17,166,099 |
| NOVARTIS AG | SPONSORED ADR | 66987V109 | PUT | 100,000 shares | $15,672,000 |
| UNIQURE NV | SHS | N90064101 | PUT | 299,000 shares | $13,771,940 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | PUT | 350,500 shares | $13,673,005 |
| BIOGEN INC | COM | 09062X103 | CALL | 60,000 shares | $12,963,600 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | PUT | 534,400 shares | $12,868,352 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | CALL | 860,200 shares | $12,533,114 |
| ELI LILLY & CO | COM | 532457108 | PUT | 10,000 shares | $11,994,300 |
| INCYTE CORP | COM | 45337C102 | PUT | 105,400 shares | $11,948,144 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 272,214 shares | $11,060,055 |
| UNIQURE NV | SHS | N90064101 | CALL | 235,400 shares | $10,842,524 |
| BIONTECH SE | SPONSORED ADS | 09075V102 | CALL | 100,000 shares | $9,305,000 |
| KODIAK SCIENCES INC | COM | 50015M109 | — | 218,117 shares | $8,497,838 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 254,863 shares | $8,091,900 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | CALL | 329,300 shares | $7,929,544 |
| NOVARTIS AG | SPONSORED ADR | 66987V109 | CALL | 50,000 shares | $7,836,000 |
| REPLIMUNE GROUP INC | COM | 76029N106 | CALL | 696,300 shares | $7,708,041 |
| KODIAK SCIENCES INC | COM | 50015M109 | CALL | 196,700 shares | $7,663,432 |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | — | 571,107 shares | $7,595,723 |
| MODERNA INC | COM | 60770K107 | PUT | 100,000 shares | $7,003,000 |
| HIMS & HERS HEALTH INC | COM CL A | 433000106 | CALL | 200,000 shares | $6,934,000 |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | — | 223,810 shares | $6,900,062 |
| HIMS & HERS HEALTH INC | COM CL A | 433000106 | PUT | 193,700 shares | $6,715,579 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | CALL | 633,800 shares | $5,945,044 |
| SELLAS LIFE SCIENCES GROUP I | COM NEW | 81642T209 | CALL | 400,000 shares | $5,904,000 |
| KODIAK SCIENCES INC | COM | 50015M109 | PUT | 146,900 shares | $5,723,224 |
| ALUMIS INC | COM | 022307102 | CALL | 200,000 shares | $5,628,000 |
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | CALL | 100,000 shares | $5,607,000 |
| JOHNSON & JOHNSON | COM | 478160104 | — | 22,000 shares | $5,587,340 |
| REPLIMUNE GROUP INC | COM | 76029N106 | PUT | 502,500 shares | $5,562,675 |
| BIOAGE LABS INC | COM | 09077V100 | CALL | 200,100 shares | $4,904,451 |
| NOVO-NORDISK A S | ADR | 670100205 | — | 100,000 shares | $4,809,442 |
| BIOHAVEN LTD | COM | G1110E107 | CALL | 317,000 shares | $4,716,960 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | CALL | 307,000 shares | $4,466,850 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 294,811 shares | $4,404,476 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 230,677 shares | $4,315,967 |
| TG THERAPEUTICS INC | COM | 88322Q108 | CALL | 75,700 shares | $4,158,958 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | CALL | 170,100 shares | $4,116,420 |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | CALL | 124,000 shares | $3,822,920 |
| UNICYCIVE THERAPEUTICS INC | COM NEW | 90466Y202 | CALL | 792,600 shares | $3,717,294 |
| ZYMEWORKS INC | COM | 98985Y108 | — | 142,132 shares | $3,715,330 |
| AMGEN INC | COM | 031162100 | CALL | 10,000 shares | $3,621,200 |
| BIOAGE LABS INC | COM | 09077V100 | — | 146,334 shares | $3,586,646 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 522,619 shares | $3,559,035 |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | CALL | 200,000 shares | $3,384,000 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | PUT | 86,000 shares | $3,200,060 |
| VAXCYTE INC | COM | 92243G108 | CALL | 53,100 shares | $3,086,703 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 121,539 shares | $2,948,536 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | PUT | 200,000 shares | $2,914,000 |
| VAXCYTE INC | COM | 92243G108 | PUT | 48,900 shares | $2,842,557 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 301,264 shares | $2,825,856 |
| INDIVIOR PHARMACEUTICALS INC | COM | 45579U109 | — | 67,512 shares | $2,770,017 |
| INVENTIVA SA | ADS | 46124U107 | — | 740,786 shares | $2,725,718 |
| NOVO-NORDISK A S | ADR | 670100205 | PUT | 55,900 shares | $2,679,846 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 27,799 shares | $2,645,631 |
| VAXCYTE INC | COM | 92243G108 | — | 45,071 shares | $2,619,977 |
| CYTOKINETICS INC | COM NEW | 23282W605 | PUT | 30,000 shares | $2,555,700 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 361,367 shares | $2,500,660 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 57,608 shares | $2,471,959 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | PUT | 50,000 shares | $2,145,500 |
| CELCUITY INC | COM | 15102K100 | CALL | 20,000 shares | $2,092,400 |
| ANNEXON INC | COM | 03589W102 | CALL | 353,200 shares | $2,016,772 |
| SEPTERNA INC | COM | 81734D104 | PUT | 59,700 shares | $1,999,353 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | CALL | 133,400 shares | $1,992,996 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 119,733 shares | $1,962,424 |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | — | 462,724 shares | $1,961,950 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 78,391 shares | $1,897,062 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | CALL | 50,900 shares | $1,893,989 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 100,000 shares | $1,837,000 |
| MACROGENICS INC | COM | 556099109 | — | 374,403 shares | $1,729,742 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 926,016 shares | $1,722,390 |
| ADMA BIOLOGICS INC | COM | 000899104 | CALL | 200,000 shares | $1,674,000 |
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | — | 30,000 shares | $1,620,000 |
| ARDELYX INC | COM | 039697107 | — | 303,025 shares | $1,545,428 |
| CUE BIOPHARMA INC | COM | 22978P205 | — | 48,369 shares | $1,526,526 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 56,347 shares | $1,520,242 |
| EYEPOINT INC | COM NEW | 30233G209 | CALL | 106,300 shares | $1,520,090 |
| SELLAS LIFE SCIENCES GROUP I | COM NEW | 81642T209 | PUT | 100,000 shares | $1,476,000 |
| PROTHENA CORP PLC | SHS | G72800108 | — | 149,482 shares | $1,463,429 |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | — | 413,642 shares | $1,447,747 |
| UNICYCIVE THERAPEUTICS INC | COM NEW | 90466Y202 | — | 303,676 shares | $1,424,240 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 129,950 shares | $1,409,958 |
| EVOLUS INC | COM | 30052C107 | CALL | 200,000 shares | $1,388,000 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 15,000 shares | $1,331,700 |
| CYBIN INC | COM NEW | 23256X407 | — | 200,000 shares | $1,322,000 |
| CORMEDIX INC | COM | 21900C308 | PUT | 167,500 shares | $1,314,875 |
| EDITAS MEDICINE INC | COM | 28106W103 | CALL | 400,000 shares | $1,296,000 |